Shanghai RAAS Blood Products (002252.SZ) - EPS (earnings per share)

EPS in 2025 (TTM): A$0.08325

According to Shanghai RAAS Blood Products's latest financial reports the company's current EPS (TTM) is A$0.08004. In 2024 the company made an earnings per share (EPS) of A$0.06479 an increase over its 2023 EPS that were of A$0.05473.

EPS history for Shanghai RAAS Blood Products from 2005 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	A$0.08325	28.5%
2024	A$0.06479	18.38%
2023	A$0.05473	-5.91%
2022	A$0.05817	36.15%
2021	A$0.04272	-7.39%
2020	A$0.04613	87.44%
2019	A$0.02461	-138.11%
2018	A-$0.06459	-272.5%
2017	A$0.03744	-45.02%
2016	A$0.06809	5.85%
2015	A$0.06433	127.47%
2014	A$0.02828	48.29%
2013	A$0.01907	29.9%
2012	A$0.01468	13.1%
2011	A$0.01298	14.18%
2010	A$0.01137	40.49%
2009	A$0.008093	13.05%
2008	A$0.007159	18.08%
2007	A$0.006063	-37.8%
2006	A$0.009747	2.48%
2005	A$0.009511

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Shanghai RAAS Blood Products (002252.SZ)